NCT04369287View on ClinicalTrials.gov

Prevalence and Clinical Effect of IDH1/2 Mutations in Patients With Acute Myeloid Leukemia

UnknownOBSERVATIONAL
Enrollment

654

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

October 15, 2020

Study Completion Date

December 15, 2020

Conditions
Acute Myeloid LeukemiaIDH1 Gene MutationIDH2 Gene Mutation
Trial Locations (1)

Unknown

RECRUITING

Istituto Clinico Humanitas, Milan

Sponsors

Collaborators (1)

Celgene
All Listed Sponsors
collaborator

Celgene

INDUSTRY

lead

Istituto Clinico Humanitas

OTHER